In comparison to the IgG-treated control group, mice treated with anti-IL-6 alone did not show any therapeutic benefit, whereas mice treated with anti-CTLA-4 alone showed an initial benefit followed by an increased tumor growth rate from day 30. This evidence concerns the gene CTLA4 and neoplasm.